Jazz Pharmaceuticals plc (JAZZ) released earnings for its fourth quarter that Increases, from the same period last year
The company's earnings totaled $203.45 million, or $3.21 per share. This compares with $191.11 million, or $3.11 per share, last year.
Excluding items, Jazz Pharmaceuticals plc reported adjusted earnings of $420.88 million or $6.64 per share for the period.
The company's revenue for the period rose 10.2% to $1.19 billion from $1.08 billion last year.
Jazz Pharmaceuticals plc earnings at a glance (GAAP) :
-Earnings: $203.45 Mln. vs. $191.11 Mln. last year.-EPS: $3.21 vs. $3.11 last year.-Revenue: $1.19 Bln vs. $1.08 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.